Correlation Between Merck and Biofrontera Warrants

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Biofrontera Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Biofrontera Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Biofrontera Warrants, you can compare the effects of market volatilities on Merck and Biofrontera Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Biofrontera Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Biofrontera Warrants.

Diversification Opportunities for Merck and Biofrontera Warrants

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Merck and Biofrontera is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Biofrontera Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera Warrants and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Biofrontera Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera Warrants has no effect on the direction of Merck i.e., Merck and Biofrontera Warrants go up and down completely randomly.

Pair Corralation between Merck and Biofrontera Warrants

Considering the 90-day investment horizon Merck Company is expected to under-perform the Biofrontera Warrants. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 70.11 times less risky than Biofrontera Warrants. The stock trades about -0.08 of its potential returns per unit of risk. The Biofrontera Warrants is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  3.90  in Biofrontera Warrants on August 29, 2024 and sell it today you would earn a total of  4.64  from holding Biofrontera Warrants or generate 118.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

Merck Company  vs.  Biofrontera Warrants

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Biofrontera Warrants 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera Warrants are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Biofrontera Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

Merck and Biofrontera Warrants Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Biofrontera Warrants

The main advantage of trading using opposite Merck and Biofrontera Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Biofrontera Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera Warrants will offset losses from the drop in Biofrontera Warrants' long position.
The idea behind Merck Company and Biofrontera Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance